Additional Subscription

In brief · summary, not quotable

Cellbxhealth plc announced an additional subscription by Conifer Management, LLC, on behalf of the Acacia funds, for 40,891,541 New Ordinary Shares at the Issue Price, raising approximately £0.4 million. This brings the total gross proceeds from the fundraising, including this additional subscription, to approximately £8.2 million. Following this, Acacia will hold 29.9% of the issued share capital. The enlarged share capital post-Second Admission is expected to be 1,139,402,658 New Ordinary Shares, with Second Admission anticipated on December 18, 2025.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes

CELLBXHEALTH plc (AIM: CLBX), a leader in circulating tumour cell (CTC) intelligence is pleased to announce that further to the closing of the Retail Offer yesterday, Conifer Management, LLC, on behalf of the Acacia funds ("Acacia''), has subscribed for a further 40,891,541 New Ordinary Shares at the Issue Price ("Additional Subscription Shares") by way of a direct subscription ("Additional Subscription"), raising further gross proceeds of approximately £0.4 million.

Acacia was the largest participant in the Fundraising and the Additional Subscription allows Acacia to ensure that it will hold 29.9% of the issued share capital following Second Admission.

The Fundraising (including the Additional Subscription) has raised, in aggregate, gross proceeds of approximately £8.2 million.

Subject to the passing of the Resolutions, the Additional Subscription Shares will be included in the Second Admission which will now be in respect of, in aggregate, 807,670,990 New Ordinary Shares comprising the Second Tranche Placing Shares, the Subscription Shares, the Retail Offer Shares and the Additional Subscription Shares. Second Admission is expected to occur at 8.00 a.m. on 18 December 2025 (or such later time and/or date as the Company and Cavendish may agree (being no later than 8.00 a.m. on 16 January 2026)).

The issued share capital of the Company following Second Admission (the "Enlarged Share Capital") will now be a total of 1,139,402,658 New Ordinary Shares.

Cavendish Capital Markets Limited ("Cavendish") acted as Nominated Adviser, Broker and Bookrunner in connection with the Fundraising.

Beech Hill Securities, Inc. acted as US Private Placement Agent in connection with the Fundraising, including with respect to Acacia.

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the announcement of the Fundraising made by the Company on 24 November 2025.

The Company's LEI is 213800BY11K6W3NMS374

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.